Abstract
Abstract
Background
Tremors, psychological difficulties, mental health issues, depression, impulsive acts, and other behavioral abnormalities are all symptoms of Parkinson's disease, a neurodegenerative disorder of the central nervous system. Smilax china ethanolic extract was tested for its anti-Parkinson's activity using a Wistar rat model of rotenone-induced Parkinson's disease. Spectroscopic, acute toxicity and pharmacognostic analyses were performed.
Result
Brownish, the bark of Smilax china included vascular bundles and fibers upon microscopic inspection and alkaloids, carbohydrates, and phenolic substances upon phytochemical analysis. Acute toxicity testing as per Organization for Economic Corporation and Development 423 (OECD 423) on male Wistar rats revealed no harmful effects. The biochemical analysis of rotenone-induced groups revealed a disproportion. Improved body weight, mobility, coordination, and a lower incidence of catalepsy were seen in animals treated with Smilax china ethanolic extract (100 and 200 mg/kg). Smilax china 200 mg/kg extract substantially lowered motor defects determined by catalepsy score using bar test 17.061.74/s against rotenone-induced group 67.593.27/s. It also prevented the brain from oxidative stress by enhancing superoxide dismutase (SOD) levels to 5.440.01 units/mg protein compared to 2.050.104 units/mg protein in the rotenone-induced group. The vagus nerve, substantia nigra, and basal ganglia of the treated groups indicated a reduction in inflammation and alpha-synuclein destruction.
Conclusion
Based on our research, an ethanolic extract of Smilax china bark provides an effective antioxidant with promising neuroprotective properties in male Wistar rats induced with Parkinson's disease.
Graphical abstract
Publisher
Springer Science and Business Media LLC
Reference71 articles.
1. Soumya Jacob P (2022) Parkinson's Disease: Neuro-Cognitive Perspective In Bio-Inspired Algorithms and Devices for Treatment of Cognitive Diseases Using Future Technologies (82–93) IGI Global
2. Pacifici F, Salimei C, Pastore D, Malatesta G, Ricordi C, Donadel G et al (2022) The protective effect of a unique mix of polyphenols and micronutrients against neurodegeneration induced by an in vitro model of Parkinson’s disease. Int J Mol Sci 23(6):3110
3. Duarte-Jurado AP, Gopar-Cuevas Y, Saucedo-Cardenas O, Loera-Arias MDJ, Montes-de-Oca-Luna R, Garcia-Garcia A et al (2021) Antioxidant therapeutics in Parkinson’s disease: current challenges and opportunities. Antioxidants 10(3):453
4. Sayyaed A, Saraswat N, Vyawahare N, Kulkarni A (2023) A detailed review of pathophysiology, epidemiology, cellular and molecular pathways involved in the development and prognosis of Parkinson’s disease with insights into screening models. Bull Natl Res Centre 47(1):1–16
5. Feng H, He Y, La L, Hou C, Song L, Yang Q et al (2020) The flavonoid-enriched extract from the root of Smilax china L inhibits inflammatory responses via the TLR-4-mediated signalling pathway. J Ethnopharmacol 256:112785
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献